STOCK TITAN

Insider Catherine Corrigan plans EXPO (NASDAQ: EXPO) stock sale under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Exponent Inc. insider Catherine Corrigan has filed a Form 144 notice to sell shares of EXPO common stock. The filing covers a planned sale of 3,920 common shares through Morgan Stanley Smith Barney LLC on or about 02/17/2026, with an aggregate market value of $261,816.80. The shares were acquired the same day by exercising stock options for cash.

The notice also reports prior Rule 10b5-1 plan sales over the past three months. These include 1,663 common shares sold on 01/15/2026 for gross proceeds of $120,593.78 and 3,225 common shares sold on 12/15/2025 for $240,171.23. Shares outstanding were 49,887,226 at the time referenced, providing context for the size of these trades.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the EXPO Form 144 filing by Catherine Corrigan disclose?

The filing discloses a planned sale of Exponent (EXPO) common stock by insider Catherine Corrigan. It details shares to be sold, market value, acquisition via option exercise, and recent 10b5-1 plan sales over the prior three months.

How many EXPO shares are planned for sale in this Form 144?

The notice covers a planned sale of 3,920 EXPO common shares. These shares were acquired by exercising stock options for cash and are to be sold through Morgan Stanley Smith Barney LLC around 02/17/2026, with an aggregate market value of $261,816.80.

What recent EXPO stock sales under Rule 10b5-1 are reported?

The filing lists two recent 10b5-1 plan sales for Catherine Corrigan: 1,663 common shares sold on 01/15/2026 for $120,593.78 and 3,225 shares sold on 12/15/2025 for $240,171.23, showing prior trading activity.

How were the EXPO shares in the planned sale acquired?

The 3,920 Exponent (EXPO) shares covered by the planned sale were acquired on 02/17/2026 through the exercise of stock options. The filing specifies that the option exercise was paid in cash, and the issuer was the source of the shares.

What is the context of EXPO shares outstanding in this Form 144?

The Form 144 notes that 49,887,226 EXPO common shares were outstanding at the referenced time. This provides context for evaluating the relative size of the planned 3,920-share sale and the prior 10b5-1 transactions disclosed in the filing.

Which broker is handling the planned EXPO share sale?

The planned sale of Exponent (EXPO) common stock will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The firm’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and it will handle the Rule 144 transaction.
Exponent Inc

NASDAQ:EXPO

EXPO Rankings

EXPO Latest News

EXPO Latest SEC Filings

EXPO Stock Data

3.51B
49.37M
Engineering & Construction
Services-management Consulting Services
Link
United States
MENLO PARK